Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Long-term Safety Study of Vusolimogene Oderparepvec, RP2, and RP3 in Patients with Melanoma, Liver Cancer, or Advanced Solid Tumors

    Recruiting

    3 1 1
    France Germany Greece Poland Spain
  • A Study Comparing MB11 and Nivolumab in Adults With Previously Untreated Advanced or Metastatic Melanoma

    Recruiting

    3 1 1 1
    Investigated drugs:
    Greece Italy Poland Portugal Romania Slovakia +1
  • Study of Heart and Blood Vessel Side Effects in Cancer Patients Receiving Immune Checkpoint Inhibitor Drug Combination Treatment

    Recruiting

    3 1 1 1
    Hungary
  • Study to Evaluate IOpener-Melanoma Test for Predicting Response to Immunotherapy in Stage III or IV Skin Melanoma Patients

    Recruiting

    3 1 1 1
    Investigated drugs:
    The Netherlands
  • Study of mRNA-4157 and Pembrolizumab for Patients with Metastatic Melanoma

    Recruiting

    2 1 1
    Investigated drugs:
    France Germany Greece Italy Poland Portugal +1
  • Vusolimogene Oderparepvec with Nivolumab for Advanced Melanoma Patients Whose Cancer Progressed After Previous Immunotherapy Treatments

    Recruiting

    3 1 1 1
    Investigated diseases:
    France Germany Greece Italy Poland Spain
  • Study on Safe Skin Test Concentrations for Biotherapy Allergies in Patients with Cancer Using Atezolizumab, Daratumumab, and Nivolumab

    Recruiting

    3 1 1 1
    France
  • Study on IMA203 for Patients with Previously Treated Unresectable or Metastatic Skin Melanoma

    Recruiting

    3 1 1 1
    France Germany The Netherlands
  • Study on Encorafenib, Binimetinib, Cemiplimab, and Fianlimab for Patients with BRAF-Mutated Melanoma and Brain Metastases

    Recruiting

    2 1 1 1
    Spain
  • Study on the Use of Indocyanine Green and Technetium (99mTc) Nanocolloid for Sentinel Node Biopsy in Patients with Melanoma, Oral Cancer, or Penile Cancer

    Recruiting

    2 1 1 1
    The Netherlands